Iff receives all required antitrust clearances for intended combination with dupont's nutrition & biosciences business

New york & wilmington, del.--(business wire)---- $iff--regulatory news: iff (nyse: iff) (euronext paris: iff) (tase: iff) and dupont (nyse: dd) today announced that the intended combination of dupont's nutrition & biosciences (n&b) business with iff has received unconditional clearance from the european commission. with receipt of this clearance, the intended combination has received all required antitrust clearances and approvals that are a condition to the closing of the transaction. “we are p
DD Ratings Summary
DD Quant Ranking